{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:12:24Z","timestamp":1787497944641,"version":"build-2736575974"},"reference-count":127,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3) is the most widely investigated inflammasome member whose overactivation can be a driver of several carcinomas. It is activated in response to different signals and plays an important role in metabolic disorders and inflammatory and autoimmune diseases. NLRP3 belongs to the pattern recognition receptors (PRRs) family, expressed in numerous immune cells, and it plays its primary function in myeloid cells. NLRP3 has a crucial role in myeloproliferative neoplasms (MPNs), considered to be the diseases best studied in the inflammasome context. The investigation of the NLRP3 inflammasome complex is a new horizon to explore, and inhibiting IL-1\u03b2 or NLRP3 could be a helpful cancer-related therapeutic strategy to improve the existing protocols.<\/jats:p>","DOI":"10.3390\/ijms24054860","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T02:27:25Z","timestamp":1677810445000},"page":"4860","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms"],"prefix":"10.3390","volume":"24","author":[{"given":"Elisa","family":"Parciante","sequence":"first","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2509-6200","authenticated-orcid":false,"given":"Cosimo","family":"Cumbo","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Anelli","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zagaria","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Redavid","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Minervini","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Conserva","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Tota","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-8186","authenticated-orcid":false,"given":"Nicoletta","family":"Coccaro","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3323-6445","authenticated-orcid":false,"given":"Francesco","family":"Tarantini","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-9906","authenticated-orcid":false,"given":"Crescenzio Francesco","family":"Minervini","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giovanna","family":"Macchia","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Specchia","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3277-6594","authenticated-orcid":false,"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-6052","authenticated-orcid":false,"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[{"name":"Hematology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u2018Aldo Moro\u2019, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nrc2047","article-title":"Myelodysplastic Syndromes: The Complexity of Stem-Cell Diseases","volume":"7","author":"Corey","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","first-page":"1136","article-title":"Acute Myeloid Leukemia","volume":"12","author":"Longo","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","article-title":"Myeloproliferative Neoplasms: A Contemporary Review","volume":"1","author":"Tefferi","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic Inflammation as a Promotor of Mutagenesis in Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis. A Human Inflammation Model for Cancer Development?","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12185-017-2262-9","article-title":"Complexity of Bone Marrow Hematopoietic Stem Cell Niche","volume":"106","author":"Asada","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic Basis and Molecular Pathophysiology of Classical Myeloproliferative Neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 Revision of the World Health Organization (WHO) Classification of Myeloid Neoplasms and Acute Leukemia: Rationale and Important Changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1476-4598-9-120","article-title":"Non Random Distribution of Genomic Features in Breakpoint Regions Involved in Chronic Myeloid Leukemia Cases with Variant t(9;22) or Additional Chromosomal Rearrangements","volume":"9","author":"Albano","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/onc.2009.524","article-title":"Genomic Segmental Duplications on the Basis of the t(9;22) Rearrangement in Chronic Myeloid Leukemia","volume":"29","author":"Albano","year":"2010","journal-title":"Oncogene"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","article-title":"Chronic Myeloid Leukaemia","volume":"385","author":"Apperley","year":"2015","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired Mutation of the Tyrosine Kinase JAK2 in Human Myeloproliferative Disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia with Myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ajh.23678","article-title":"CALR Mutations in Myeloproliferative Neoplasms: Hidden behind the Reticulum","volume":"89","author":"Guglielmelli","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-Mutated or Triple-Negative Myelofibrosis: Clinical, Cytogenetic and Molecular Comparisons","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3324\/haematol.2014.113845","article-title":"Molecular Determinants of Pathogenesis and Clinical Phenotype in Myeloproliferative Neoplasms","volume":"102","author":"Grinfeld","year":"2017","journal-title":"Haematologica"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/bloodadvances.2016000208","article-title":"Targeted Deep Sequencing in Primary Myelofibrosis","volume":"1","author":"Tefferi","year":"2016","journal-title":"Blood Adv."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2013-11-537167","article-title":"Clonal Evolution and Clinical Correlates of Somatic Mutations in Myeloproliferative Neoplasms","volume":"123","author":"Lundberg","year":"2014","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"825611","DOI":"10.3389\/fcell.2021.825611","article-title":"Inflammasome Activation in Myeloid Malignancies-Friend or Foe?","volume":"9","author":"Andina","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Missiroli, S., Perrone, M., Boncompagni, C., Borghi, C., Campagnaro, A., Marchetti, F., Anania, G., Greco, P., Fiorica, F., and Pinton, P. (2021). Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers, 13.","DOI":"10.3390\/cancers13102297"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102476","DOI":"10.1155\/2015\/102476","article-title":"MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives","volume":"2015","author":"Hasselbalch","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1182\/blood.V128.22.3134.3134","article-title":"Endothelial JAK2V617F Expression Drives Inflammation and Cellular Senescence; New Evidence for the Roles of Endothelial Cells in MPN-Related Clotting Abnormalities?","volume":"128","author":"Cosgrove","year":"2016","journal-title":"Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"284706","DOI":"10.1155\/2015\/284706","article-title":"Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development","volume":"2015","author":"Geyer","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-Related Inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","article-title":"Targeting the Interleukin-1 Pathway in Patients with Hematological Disorders","volume":"129","author":"Netea","year":"2017","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature13383","article-title":"Neuropathy of Haematopoietic Stem Cell Niche Is Essential for Myeloproliferative Neoplasms","volume":"512","author":"Arranz","year":"2014","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of Assembly, Regulation and Signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2019-129800","article-title":"IL-1\u03b2 Secreted from Mutant Cells Carrying JAK2-V617Ffavors Early Clonal Expansion and Promotes MPN Disease Initiation and Progression","volume":"134","author":"Rai","year":"2019","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative Neoplasms and Inflammation: Whether to Target the Malignant Clone or the Inflammatory Process or Both","volume":"30","author":"Koschmieder","year":"2016","journal-title":"Leukemia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/bloodadvances.2018026450","article-title":"Defective Negative Regulation of Toll-like Receptor Signaling Leads to Excessive TNF-\u03b1 in Myeloproliferative Neoplasm","volume":"3","author":"Lai","year":"2019","journal-title":"Blood Adv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A Guide to Immunometabolism for Immunologists","volume":"16","author":"Kishton","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100005","DOI":"10.1016\/j.cytox.2019.100005","article-title":"Cytokines Frequently Implicated in Myeloproliferative Neoplasms","volume":"1","author":"Wang","year":"2019","journal-title":"Cytokine X"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","article-title":"Inflammation and Myeloproliferative Neoplasms","volume":"85","author":"Lussana","year":"2017","journal-title":"J. Autoimmun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern Recognition Receptors and Inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 Inflammasome and Its Inhibitors: A Review","volume":"6","author":"Shao","year":"2015","journal-title":"Front. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","article-title":"Chronic Immune Response Dysregulation in MDS Pathogenesis","volume":"132","author":"Barreyro","year":"2018","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/leu.2015.69","article-title":"Deregulation of Innate Immune and Inflammatory Signaling in Myelodysplastic Syndromes","volume":"29","author":"Wei","year":"2015","journal-title":"Leukemia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41568-019-0123-y","article-title":"Diverging Inflammasome Signals in Tumorigenesis and Potential Targeting","volume":"19","author":"Karki","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The Inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/eji.201746947","article-title":"Function and Mechanism of the Pyrin Inflammasome","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.it.2022.10.007","article-title":"Humans PIKK-up NLRP3 to Skip NEK7","volume":"43","author":"Malireddi","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 Inflammasome in Dendritic Cells Induces IL-1\u03b2\u2013Dependent Adaptive Immunity against Tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in Health and Disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-014-0080-6","article-title":"Immunosuppressive\/Anti-Inflammatory Cytokines Directly and Indirectly Inhibit Endothelial Dysfunction-A Novel Mechanism for Maintaining Vascular Function","volume":"7","author":"Shao","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","article-title":"The Role of Inflammatory Cytokines in Endothelial Dysfunction","volume":"103","author":"Zhang","year":"2008","journal-title":"Basic Res. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 Inflammasome: Molecular Activation and Regulation to Therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41375-020-0827-8","article-title":"The Nlrp3 Inflammasome as a \u201cRising Star\u201d in Studies of Normal and Malignant Hematopoiesis","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E7766","DOI":"10.1073\/pnas.1702946114","article-title":"NLRP3 Mutation and Cochlear Autoinflammation Cause Syndromic and Nonsyndromic Hearing Loss DFNA34 Responsive to Anakinra Therapy","volume":"114","author":"Nakanishi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/art.41245","article-title":"Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis","volume":"72","author":"Yang","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2017.10.011","article-title":"Recent Advances In Inflammasome Biology","volume":"50","author":"Place","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/JIR.S141220","article-title":"Spotlight on the NLRP3 Inflammasome Pathway","volume":"11","author":"Groslambert","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"109595","DOI":"10.1016\/j.biopha.2019.109595","article-title":"Pyroptosis: A New Frontier in Cancer","volume":"121","author":"Fang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent Advances in the Mechanisms of NLRP3 Inflammasome Activation and Its Inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5702103","DOI":"10.1155\/2018\/5702103","article-title":"NLRP3: A Novel Mediator in Cardiovascular Disease","volume":"2018","author":"Zhou","year":"2018","journal-title":"J. Immunol. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/bloodadvances.2020003475","article-title":"Oxidized Mitochondrial DNA Released after Inflammasome Activation Is a Disease Biomarker for Myelodysplastic Syndromes","volume":"5","author":"Ward","year":"2021","journal-title":"Blood Adv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and Regulation of the Inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2008-03-146720","article-title":"Differential Requirement for the Activation of the Inflammasome for Processing and Release of IL-1beta in Monocytes and Macrophages","volume":"113","author":"Netea","year":"2009","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1020506300324","article-title":"Interleukin-18 and Interleukin-1 Beta: Two Cytokine Substrates for ICE (Caspase-1)","volume":"19","author":"Fantuzzi","year":"1999","journal-title":"J. Clin. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: Host Cell Death and Inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter","volume":"38","author":"Kuffa","year":"2013","journal-title":"Immunity"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 Cleaves Gasdermin D for Non-Canonical Inflammasome Signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/eji.201545523","article-title":"Caspase-4 Mediates Non-Canonical Activation of the NLRP3 Inflammasome in Human Myeloid Cells","volume":"45","author":"Gaidt","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41467-018-03409-3","article-title":"The Oxidized Phospholipid OxPAPC Protects from Septic Shock by Targeting the Non-Canonical Inflammasome in Macrophages","volume":"9","author":"Chu","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ni1344","article-title":"Cytoplasmic Flagellin Activates Caspase-1 and Secretion of Interleukin 1beta via Ipaf","volume":"7","author":"Miao","year":"2006","journal-title":"Nat. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human Monocytes Engage an Alternative Inflammasome Pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile Inflammation: Sensing and Reacting to Damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12015-019-09890-7","article-title":"The Nlrp3 Inflammasome Orchestrates Mobilization of Bone Marrow-Residing Stem Cells into Peripheral Blood","volume":"15","author":"Lenkiewicz","year":"2019","journal-title":"Stem Cell Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-018-0087-z","article-title":"Mobilization of Hematopoietic Stem Cells as a Result of Innate Immunity-Mediated Sterile Inflammation in the Bone Marrow Microenvironment\u2014The Involvement of Extracellular Nucleotides and Purinergic Signaling","volume":"32","author":"Ratajczak","year":"2018","journal-title":"Leukemia"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/leu.2016.278","article-title":"Novel Evidence That the Mannan-Binding Lectin Pathway of Complement Activation Plays a Pivotal Role in Triggering Mobilization of Hematopoietic Stem\/Progenitor Cells by Activation of Both the Complement and Coagulation Cascades","volume":"31","author":"Adamiak","year":"2017","journal-title":"Leukemia"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nri.2016.151","article-title":"Homeostasis-Altering Molecular Processes as Mechanisms of Inflammasome Activation","volume":"17","author":"Liston","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.celrep.2015.05.046","article-title":"MTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation","volume":"12","author":"Moon","year":"2015","journal-title":"Cell Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/eji.201546131","article-title":"A Novel \u201cComplement-Metabolism-Inflammasome Axis\u201d as a Key Regulator of Immune Cell Effector Function","volume":"46","author":"Arbore","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"NEK7 Is an Essential Mediator of NLRP3 Activation Downstream of Potassium Efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.immuni.2022.10.021","article-title":"IKK\u03b2 Primes Inflammasome Formation by Recruiting NLRP3 to the Trans-Golgi Network","volume":"55","author":"Schmacke","year":"2022","journal-title":"Immunity"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1084\/jem.20171922","article-title":"TAK1 Restricts Spontaneous NLRP3 Activation and Cell Death to Control Myeloid Proliferation","volume":"215","author":"Malireddi","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/iub.1210","article-title":"Biochemical and Structural Aspects of the ATP-Binding Domain in Inflammasome-Forming Human NLRP Proteins","volume":"65","author":"Macdonald","year":"2013","journal-title":"IUBMB Life"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41422-020-0295-8","article-title":"Toward Targeting Inflammasomes: Insights into Their Regulation and Activation","volume":"30","author":"Christgen","year":"2020","journal-title":"Cell Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Kelley, N., Jeltema, D., Duan, Y., and He, Y. (2019). The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133328"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"19487","DOI":"10.1074\/jbc.M116.741082","article-title":"ASC Pyrin Domain Self-Associates and Binds NLRP3 Protein Using Equivalent Binding Interfaces","volume":"291","author":"Oroz","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"676","DOI":"10.12688\/f1000research.18557.1","article-title":"Right Place, Right Time: Localisation and Assembly of the NLRP3 Inflammasome","volume":"8","author":"Hamilton","year":"2019","journal-title":"F1000Res"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular Mechanisms Regulating NLRP3 Inflammasome Activation","volume":"13","author":"Jo","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-017-0027-2","article-title":"Mitochondria-Associated Membranes (MAMs) and Inflammation","volume":"9","author":"Missiroli","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fimmu.2020.01444","article-title":"NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-018-0900-3","article-title":"Role of the NLRP3 Inflammasome in Cancer","volume":"17","author":"Moossavi","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/s41467-019-12370-8","article-title":"NLRP3 Inflammasome in Fibroblasts Links Tissue Damage with Inflammation in Breast Cancer Progression and Metastasis","volume":"10","author":"Ershaid","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Tomasik, J., and Basak, G.W. (2022). Inflammasomes-New Contributors to Blood Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158129"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 Inflammasome Functions as a Driver of the Myelodysplastic Syndrome Phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1172\/JCI71543","article-title":"Divergence of IL-1, IL-18, and Cell Death in NLRP3 Inflammasomopathies","volume":"123","author":"Brydges","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4049\/jimmunol.177.1.234","article-title":"IL-18 Bridges Innate and Adaptive Immunity through IFN-\u03b3 and the CD134 Pathway","volume":"177","author":"Maxwell","year":"2006","journal-title":"J. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory Cytokines Lowering Erythropoietin Production","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J. Interferon. Cytokine Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.humimm.2020.09.001","article-title":"Genetic Polymorphisms and Expression of NLRP3 Inflammasome-Related Genes Are Associated with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms","volume":"81","author":"Zhou","year":"2020","journal-title":"Hum. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.critrevonc.2015.11.004","article-title":"Myeloproliferative Neoplasms: Current Molecular Biology and Genetics","volume":"98","author":"Saeidi","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humimm.2017.10.013","article-title":"The Genetic Polymorphism and Expression Profiles of NLRP3 Inflammasome in Patients with Chronic Myeloid Leukemia","volume":"79","author":"Zhang","year":"2018","journal-title":"Hum. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/scisignal.abh1083","article-title":"Tyrosine Kinase Inhibitors Can Activate the NLRP3 Inflammasome in Myeloid Cells through Lysosomal Damage and Cell Lysis","volume":"16","author":"Neuwirt","year":"2023","journal-title":"Sci. Signal."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nchem.1961","article-title":"Imaging the Intracellular Distribution of Tyrosine Kinase Inhibitors in Living Cells with Quantitative Hyperspectral Stimulated Raman Scattering","volume":"6","author":"Fu","year":"2014","journal-title":"Nat. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3324\/haematol.2009.008631","article-title":"ABC Transporter A3 Facilitates Lysosomal Sequestration of Imatinib and Modulates Susceptibility of Chronic Myeloid Leukemia Cell Lines to This Drug","volume":"94","author":"Chapuy","year":"2009","journal-title":"Haematologica"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1042\/BST20140145","article-title":"Lysosomotropic Agents: Impact on Lysosomal Membrane Permeabilization and Cell Death","volume":"42","author":"Appelqvist","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00204-022-03245-x","article-title":"Imatinib-Induced Hepatotoxicity via Oxidative Stress and Activation of NLRP3 Inflammasome: An in Vitro and in Vivo Study","volume":"96","author":"Huang","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/leu.2016.377","article-title":"Mass Cytometry Analysis Reveals Hyperactive NF Kappa B Signaling in Myelofibrosis and Secondary Acute Myeloid Leukemia","volume":"31","author":"Fisher","year":"2017","journal-title":"Leukemia"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1172\/JCI31772","article-title":"TNF-\u03b1 Induces Leukemic Clonal Evolution Ex Vivo in Fanconi Anemia Group C Murine Stem Cells","volume":"117","author":"Li","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2004-05-1812","article-title":"Prevalence of Anemia in Persons 65 Years and Older in the United States: Evidence for a High Rate of Unexplained Anemia","volume":"104","author":"Guralnik","year":"2004","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ejh.13198","article-title":"Inflammatory Functional Iron Deficiency Common in Myelofibrosis, Contributes to Anaemia and Impairs Quality of Life. From the Nordic MPN Study Group","volume":"102","author":"Birgegard","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"MiR-146a Is a Significant Brake on Autoimmunity, Myeloproliferation, and Cancer in Mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-KappaB-Dependent Induction of MicroRNA MiR-146, an Inhibitor Targeted to Signaling Proteins of Innate Immune Responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.31557\/APJCP.2021.22.11.3585","article-title":"Predictive Value of MiR-146a Rs2431697 Polymorphism to Myelofibrosis Progression in Patients with Myeloproliferative Neoplasm","volume":"22","author":"Aref","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D Causes Myeloproliferation via NLRP3 Inflammasome Activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13045-020-00995-y","article-title":"Novel Therapeutics in Myeloproliferative Neoplasms","volume":"13","author":"Venugopal","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17474086.2022.2112565","article-title":"Pacritinib for the Treatment of Patients with Myelofibrosis and Thrombocytopenia","volume":"15","author":"Mascarenhas","year":"2022","journal-title":"Expert. Rev. Hematol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Bose, P., Masarova, L., and Verstovsek, S. (2020). Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms. Cancers, 12.","DOI":"10.3390\/cancers12102891"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"eaba4380","DOI":"10.1126\/scitranslmed.aba4380","article-title":"Calreticulin Mutant Myeloproliferative Neoplasms Induce MHC-I Skewing, Which Can Be Overcome by an Optimized Peptide Cancer Vaccine","volume":"14","author":"Gigoux","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood-2022-159435","article-title":"Discovery of INCA033989, a Monoclonal Antibody That Selectively Antagonizes Mutant Calreticulin Oncogenic Function in Myeloproliferative Neoplasms (MPNs)","volume":"140","author":"Reis","year":"2022","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cei\/uxab023","article-title":"The Autoimmune Encephalitis-Related Cytokine TSLP in the Brain Primes Neuroinflammation by Activating the JAK2-NLRP3 Axis","volume":"207","author":"Yu","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"714943","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2\/STAT3 Pathway Inhibition","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41408-021-00547-8","article-title":"Therapeutic Targeting of the Inflammasome in Myeloid Malignancies","volume":"11","author":"Chakraborty","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"di Battista, V., Bochicchio, M.T., Giordano, G., Napolitano, M., and Lucchesi, A. (2021). Genetics and Pathogenetic Role of Inflammasomes in Philadelphia Negative Chronic Myeloproliferative Neoplasms: A Narrative Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020561"},{"key":"ref_118","first-page":"2113","article-title":"NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1\u03b2 Pathway","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2020.10.024","article-title":"NLRP3 Inflammasome Upregulates PD-L1 Expression and Contributes to Immune Suppression in Lymphoma","volume":"497","author":"Lu","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2019001950","article-title":"Danger-Associated Extracellular ATP Counters MDSC Therapeutic Efficacy in Acute GVHD","volume":"134","author":"Koehn","year":"2019","journal-title":"Blood"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","article-title":"\u03922-Microglobulin Triggers NLRP3 Inflammasome Activation in Tumor-Associated Macrophages to Promote Multiple Myeloma Progression","volume":"54","author":"Hofbauer","year":"2021","journal-title":"Immunity"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbrc.2021.03.115","article-title":"NLRP3 Inflammasome and Bruton Tyrosine Kinase Inhibition Interferes with Upregulated Platelet Aggregation and in Vitro Thrombus Formation in Sickle Cell Mice","volume":"555","author":"Vogel","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A Small-Molecule Inhibitor of the NLRP3 Inflammasome for the Treatment of Inflammatory Diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/bloodadvances.2018021709","article-title":"The Platelet NLRP3 Inflammasome Is Upregulated in Sickle Cell Disease via HMGB1\/TLR4 and Bruton Tyrosine Kinase","volume":"2","author":"Vogel","year":"2018","journal-title":"Blood Adv."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fcell.2021.630479","article-title":"Targeting the NLRP3 Inflammasome via BTK","volume":"9","author":"Weber","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1038\/ncomms8360","article-title":"Bruton\u2019s Tyrosine Kinase Is Essential for NLRP3 Inflammasome Activation and Contributes to Ischaemic Brain Injury","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","article-title":"The Central Role of Inflammatory Signaling in the Pathogenesis of Myelodysplastic Syndromes","volume":"133","author":"Sallman","year":"2019","journal-title":"Blood"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4860\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:46:24Z","timestamp":1760121984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/4860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":127,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24054860"],"URL":"https:\/\/doi.org\/10.3390\/ijms24054860","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]}}}